Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Microbiome and mycobiome from oral samples of SARS-CoV-2 infected and non infected individuals

ABSTRACT: Oral mircobiome and mycobiome of SARS-CoV-2 infected and non infected individuals

PROVIDER: PRJNA780671 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17012632_1.fastq.gz	Fastqsanger.gz
	SRR17012632_2.fastq.gz	Fastqsanger.gz
	SRR17012633_1.fastq.gz	Fastqsanger.gz
	SRR17012633_2.fastq.gz	Fastqsanger.gz
	SRR17012634_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 216

Similar Datasets

Nasopharyngeal microbiome of SARS-CoV-2 infected and non infected individuals

Project description:Nasopharyngeal microbiome of SARS-CoV-2 infected and non infected individuals Raw sequence reads

| PRJNA707350 | ENA

Mycobiome profiling of nasopharyngeal region of SARS-CoV-2 infected individuals

Project description:The present cross-sectional study aims to explore the fungal community composition of the nasopharyngeal region of SARS-CoV-2 infected individuals and how the infection influences the mycobiome therein. The infection significantly (p<0.05) influenced the alpha diversity. Interestingly, a higher abundance of Cladosporium and Alternaria was noted in the infected individuals and inter-individual variation in mycobiome composition was well supported by beta dispersion analysis (p < 0.05). Moreover, decrease in Aspergillus abundance was observed in infected patients across the four age groups. This study provides insight into the alteration in mycobiome during the viral disease progression and demands continuous investigation to monitor fungal infections.

| S-EPMC9553963 | biostudies-literature

Type I interferon pathways in SARS-CoV-2-infected individuals from Pakistan

Project description:Type I interferon pathways in SARS-CoV-2-infected individuals from Pakistan

| PRJNA737074 | ENA

THE ORAL MYCOBIOME AND RISK OF PANCREATIC CANCER

Project description:THE ORAL MYCOBIOME AND RISK OF PANCREATIC CANCER

| PRJNA1242417 | ENA

THE ORAL MYCOBIOME AND RISK OF PANCREATIC CANCER

Project description:THE ORAL MYCOBIOME AND RISK OF PANCREATIC CANCER

| PRJNA1242418 | ENA

human oral metagenome

Project description:The oral microbiome in HIV infected individuals

| PRJNA285477 | ENA

Recapitulation of pathophysiological features of AD in SARS-CoV-2 infected subjects

Project description:Infection with the etiological agent of COVID-19, SARS-CoV-2, appears capable of impacting cognition, which some patients with Post-acute Sequelae of SARS-CoV-2 (PASC). To evaluate neuro-pathophysiological consequences of SARS-CoV-2 infection, we examine transcriptional and cellular signatures in the Broadman area 9 (BA9) of the frontal cortex and the hippocampal formation (HF) in SARS-CoV-2, Alzheimer’s disease (AD) and SARS-CoV-2 infected AD individuals, compared to age- and gender-matched neurological cases. Here we show similar alterations of neuroinflammation and blood-brain barrier integrity in SARS-CoV-2, AD, and SARS-CoV-2 infected AD individuals. Distribution of microglial changes reflected by the increase of Iba-1 reveal nodular morphological alterations in SARS-CoV-2 infected AD individuals. Similarly, HIF-1α is significantly upregulated in the context of SARS-CoV-2 infection in the same brain regions regardless of AD status. The finding may help to inform decision-making regarding therapeutic treatments in patients with neuro-PASC, especially those at increased risk of developing AD.

2023-07-11 | GSE236562 | GEO

E-GEOD-38616

Project description:Transcription profiling of primary oral mucosa from oral lichen planus patients and healthy individuals

2025-01-24 | E-GEOD-38616 | ExpressionAtlas

The oral mycobiome of children with and without dental caries

Project description:The oral mycobiome of children with and without dental caries

| PRJEB28833 | ENA

human oral metagenome

Project description:Oral mycobiome across stages of oral carcinogenesis

| PRJNA777754 | ENA